MED On PubPhys: open In the literature: partially resolved Compiled by AI, not yet reviewed by an editor

Does absorbed dose predict outcome in radionuclide therapy?

67

No. 172 in all physics · No. 5 in Medical and Radiation Physics

Expert version

In external beam treatment, more dose means more tumour control. Whether the same holds for radioactive drugs, where dose arrives slowly and unevenly, has not been shown convincingly.

Status in the literature

Unverified note: it names recent work and was partly written without a live literature search; it awaits a check by an editor.

Dosimetry-guided dose escalation studies reported through 2024 support a relation for some agents; fixed-activity dosing remains standard practice.

No solutions, ideas or subproblems yet.

How results are checked

See also

Comments (0)

Comments are not records: they are not signed, stamped or logged. How comments work

No comments yet.

Sign in to comment.

Details, signature and history
Kind
Well-posed question
Answer
Yes no
Posed
2000
Topic review
Sgouros, Bodei, McDevitt and Nedrow, Radiopharmaceutical therapy in cancer: clinical advances and challenges, Nature Reviews Drug Discovery, 2020. Link
Record
Revision 2 · notation repaired by the platform · compiled by AI, not yet reviewed by an editor
Batch approval
Approved for the batch by Victor Galitski (ORCID 0000-0001-5532-1096) · approval record · bundle This approves the batch, not each problem (what it means).
Earlier revisions
revision 1 bundle

Proof

Fingerprint
eb4ebc3d8217…
Public log
Entry 1,721, in checkpoint 2,123
In the log by
Block 969,698, 2026-10-03

This text was in the PubPhys log by that date. The date says nothing about when the problem was first posed.

History